期刊文献+

microRNA-224在肝细胞癌组织和血浆中表达的相关性 被引量:7

Correlation of microRNA-224 expression between tumorous tissue and plasma in hepatocellular carcinoma
下载PDF
导出
摘要 目的探讨microRNA-224(miR-224)在肝细胞癌(hepatocellular carcinoma,HCC)患者癌组织与血浆中表达的相关性。方法采用qRT-PCR检测20例HCC患者的癌组织、癌旁组织、术前血浆及20例健康人血浆的miR-224表达量,比较癌组织与癌旁组织、HCC患者与健康人血浆miR-224的表达差异,分析miR-224在HCC血浆与癌组织中表达的相关性。结果①miR-224在HCC癌组织、癌旁组织、血浆及健康人血浆中的平均表达量分别为(0.14±0.04)、(0.02±0.01)、(1.15±0.26)和(0.11±0.03)。癌组织miR-224表达量高于癌旁组织(P<0.01),HCC患者血浆miR-224表达量高于健康人血浆(P<0.01);②miR-224在HCC血浆及相应癌组织中的相对表达量呈正相关(P<0.001)。结论 HCC血浆miR-224表达量高于健康人群,并与肝癌组织表达量呈正相关,血浆miR-224有可能成为一种新的血清学指标用于肝癌诊断。 [Objective] To investigate the correlation of microRNA-224 (miR-224) expression between plasma and tumorous tissue in HCC patients. [Methods] The expression of miR-224 in HCC tumorous tissues, adjacent nontumorous tissues and plasma was detected by qRT-PCR in 20 cases of HCC patients, and the expression of miR-224 was also detected in 20 cases of healthy human plasma, the difference of miR-224 expression between tumorous tissues and adjacent nontumorous tissues was compared, and the difference of miR-224 expression between HCC plasma and healthy human plasma was also compared, then the correlation of miR-224 expression between plasma and tumorous tissue in HCC patients was analyzed. [Results ] The average of miR-224 expression in HCC tumorous tissues, adjacent nontumorous tissues, plasma and healthy human plasma were (0.14±0.04), (0.02±0.01), (1.15±0.26), (0.11±0.03), (P〈0.01), respectively. The expression of miR-224 in tumorous tissues was significantly higher than that in adjacent nontumorous tissues (P 〈0.01), the expression of miR-224 in HCC plasma was significantly higher than that in healthy human plasma (P〈0.01). There was a positive correlation of miR-224 expression between plasma and tumorous tissue in HCC patients (P〈0.001). [Conclusions] The expression of miR-224 in HCC plasma is significantly higher than that in healthy human plasma, the expression of miR-224 in HCC plasma is positively correlated with that in HCC tumorous tissue. The plasma miR-224 may be a new serum biomarker for diagnosis of HCC.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2011年第32期4012-4016,4021,共6页 China Journal of Modern Medicine
基金 广西自然科学基金(No:2011GXNSFA018307) 广西自然科学基金重点项目(No:2011GXNSFD018032)
关键词 microRNA-224 肝细胞癌 血浆 癌组织 microRNA-224 hepatoeellular carcinoma plasma tumorous tissue
  • 相关文献

参考文献3

二级参考文献40

  • 1Ping'an ZHU,Deming TAN,Zhongtian PENG,Fei LIU,Lin SONG.Polymorphism Analyses of Hepatitis B Virus X Gene in Hepatocellular Carcinoma Patients from Southern China[J].Acta Biochimica et Biophysica Sinica,2007,39(4):265-272. 被引量:29
  • 2Duffy MJ. Clinical uses of tumor markers: a critical review. Crit Rev Clin Lab Sci 2001; 38:225-262. 被引量:1
  • 3Thomas CM, Sweep CG. Serum tumor markers: past, state of the art, and future, lnt J Biol Markers 2001; 16:73-86. 被引量:1
  • 4Duffy MJ. Role of tumor markers in patients with solid cancers: a critical review. Eur J lntern Med 2007; 18:175-184. 被引量:1
  • 5Roulston JE. Limitations of tumour markers in screening. Br J Surg 1990; 77:961-962. 被引量:1
  • 6Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 2006; 6:259-269. 被引量:1
  • 7Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6:857-866. 被引量:1
  • 8Chen C, Ridzon DA, Broomer A J, et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 2005; 33:e179. 被引量:1
  • 9Tang F, Hajkova P, Barton SC, Lao K, Surani MA. MicroRNA expression profiling of single whole embryonic stem cells. Nucleic Acids Res 2006; 34:e9. 被引量:1
  • 10Hafner M, Landgraf P, Ludwig J, et al. Identification of microRNAs and other small regulatory RNAs using cDNA library sequencing. Methods 2008; 44:3-12. 被引量:1

共引文献992

同被引文献33

  • 1Zhang B, Pan X, Cobb GP, et al. microRNAs as oncogenes and tumor suppressors[J]. Dev Biol, 2007,302:1-12. 被引量:1
  • 2Mitchell PS, Parkin RK, Kroh EM, et al. Circulating microR NAs as stable blood based markers for cancer detection[J]. Proc Natl Acad Sci U S A, 2008,105:10513-10518. 被引量:1
  • 3t Farazi TA, Spitzer JI, Morozov P, et al. miRNAs in human cancer [J] . J Pathol, 2011, 223 (2) : 102- 115. 被引量:1
  • 4Xie B, Ding Q, Han H, et al. miRCancer: a microRNA - cancer association database constructed by text mining on liter- ature [J] . Bioinformaties, 2013, 29 (5): 638-644. 被引量:1
  • 5Pritchard CC, Kroh E, Wood B, et al. Blood cell origin of circulating microRNAs: a cautionary note for cancer biomark- er studies [ J] .Cancer Prey Res, 2012, 5 (3): 492 - 497. 被引量:1
  • 6Meng F, Henson R, Wehbe-Janek H, et al. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatoeellular cancer[J]. Gastroenterology, 2007, 133(2):647-658. 被引量:1
  • 7Chung GE, Yoon JH, Myung S J, et al. High expression of microRNA-15b predicts a low risk of tumor recurrence following curative resection of hepatoeellular carcinoma[J]. Oncol Pep, 2010, 23(1):113-119. 被引量:1
  • 8Wang G, Sun Y, He Y, et al. miR-26a promoted by interferon-alpha inhibits hepatocellular carcinoma proliferation and migration by blocking EZH2[J]. Genet Test/viol Biomarkers,2015, 19(1):30-36. 被引量:1
  • 9Lena J Chin Frank J Slack.A truth serum for cancer -- microRNAs have major potential as cancer biomarkers[J].Cell Research,2008,18(10):983-984. 被引量:39
  • 10Xi Chen,Yi Ba,Lijia Ma,Xing Cai,Yuan Yin,Kehui Wang,Jig ang Guo,Yujing Zhang,Jiangning Chen,Xing Guo,Qibin Li,Xiaoying Li,Wenjing Wang,Yan Zhang,Jin Wang,Xueyuan Jiang,Yang Xiang,Chen Xu,Pingping Zheng,Juanbin Zhang,Ruiqiang Li,Hongjie Zhang,Xiaobin Shang,Ting Gong,Guang Ning,Jun Wang,Ke Zen,Junfeng Zhang,Chen-Yu Zhang.Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases[J].Cell Research,2008,18(10):997-1006. 被引量:985

引证文献7

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部